Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Oxytocin in Neuropathic Pain
NCT02100956Phase 2Terminated
- Sponsor
- Wake Forest University Health Sciences
- Start
- Jun 2014
- Primary completion
- Oct 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in neuropathic pain, sponsored by Wake Forest University Health Sciences. Started Jun 2014; status: terminated.
02
Drugs
oxytocin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT02100956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02100956.